Literature DB >> 9325192

Spontaneous induction of nitric oxide- and prostaglandin E2-release by hypoxic astroglial cells is modulated by interleukin 1 beta.

V Mollace1, C Muscoli, D Rotiroti, G Nisticó.   

Abstract

The effect of 0, 30, 60, 120, 240, 360 min hypoxia on the release of NO and PGE2 was investigated in human cultured astroglial cells. Exposure of astroglial cells to hypoxic injury produced a dose-dependent increase of the nitrite (the breakdown product of NO) level in the cell supernatant. In addition, a significant activation of the inducible isoform of NO synthase was seen, demonstrating that the enhancement on NO release produced by hypoxic injury was related to an increased biosynthesis of NO-generating enzyme(s). This effect was strongly antagonised by pretreating cells with dexamethasone (20 microM). The increase in NO release by hypoxic astroglial cells was accompanied by sustained release of PGE2, which was antagonised by the cyclooxygenase inhibitor indomethacin (10 microM), and partially attenuated by L-NAME (100 microM), a nitric oxide synthase inhibitor, showing that the release of PGE2 was driven by NO. Finally, inducible NOS activity elicited by hypoxic injury, was antagonised by incubating astroglial cells with antibodies directed against type 2 receptor for IL1 beta. In conclusion, hypoxia stimulates cytokine network in astroglial cells leading to enhanced release of NO and prostanoids and this may represent a key mechanism in cerebral blood flow disturbances.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9325192     DOI: 10.1006/bbrc.1997.7155

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Influence of indomethacin on the ventilatory and cerebrovascular responsiveness to hypoxia.

Authors:  Jui-Lin Fan; Keith R Burgess; Kate N Thomas; Karen C Peebles; Samuel J E Lucas; Rebekah A I Lucas; James D Cotter; Philip N Ainslie
Journal:  Eur J Appl Physiol       Date:  2010-10-12       Impact factor: 3.078

2.  Neuropeptide Y modulation of interleukin-1{beta} (IL-1{beta})-induced nitric oxide production in microglia.

Authors:  Raquel Ferreira; Sara Xapelli; Tiago Santos; Ana Paula Silva; Armando Cristóvão; Luísa Cortes; João O Malva
Journal:  J Biol Chem       Date:  2010-10-19       Impact factor: 5.157

Review 3.  Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications.

Authors:  Daniela Salvemini; Sangwon F Kim; Vincenzo Mollace
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-06       Impact factor: 3.619

4.  Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia.

Authors:  S Nogawa; C Forster; F Zhang; M Nagayama; M E Ross; C Iadecola
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

5.  High TNF-alpha plasma levels and macrophages iNOS and TNF-alpha expression as risk factors for painful diabetic neuropathy.

Authors:  Thomas Eko Purwata
Journal:  J Pain Res       Date:  2011-06-29       Impact factor: 3.133

6.  Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1beta production.

Authors:  Cinzia Dello Russo; Anne I Boullerne; Vitaliy Gavrilyuk; Douglas L Feinstein
Journal:  J Neuroinflammation       Date:  2004-06-30       Impact factor: 8.322

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.